Zobrazeno 41 - 50
of 103
pro vyhledávání: ''
Autor:
Andreas Alexandrou, C. Papadias, A Sarandakou, Constantinos Panoulis, Theodoros Liakakos, Georgios Creatsas, George Christodoulakos, Irene Lambrinoudaki
Publikováno v:
European Journal of Endocrinology. :187-192
OBJECTIVE: To evaluate the effect of continuous combined hormone therapy (HT), tibolone and raloxifene on circulating vascular endothelial growth factor (VEGF) in postmenopausal women. DESIGN: One-year prospective intervention study. METHODS: One hun
Publikováno v:
European Journal of Endocrinology. :265-270
OBJECTIVE: Agouti protein (AP) and agouti-related protein with a similar sequence and action are endogenous antagonists of melanocortin receptors, implicated in the control of the hypothalamo-pituitary-adrenal (HPA) axis. Dominant mutation of the ago
Autor:
H. Tukiainen, Antti Taivainen, Senja Kannisto, Anne K. Laatikainen, Kari Savolainen, Raimo Voutilainen
Publikováno v:
European Journal of Endocrinology. :687-690
OBJECTIVE: Supraphysiological doses of exogenous glucocorticosteroids cause adrenocortical suppression. Dehydroepiandrosterone sulfate (DHEA-S) is the most abundant adrenal androgen and estrogen precursor. We studied to what extent inhaled glucocorti
Publikováno v:
European Journal of Endocrinology. :473-480
OBJECTIVE: Lanreotide Autogel is a sustained-release aqueous gel formulation supplied in a prefilled syringe, with injection volume 4 months, with serum GH levels 5.0 mU/l, Autogel was reduced to 60 mg, maintained at 90 mg, or increased to 120 mg res
Publikováno v:
European Journal of Endocrinology. :539-546
OBJECTIVE: To explore effects on serum lipids, pituitary-gonadal axis, prostate and bone turnover of the administration of the mixed oestrogen agonist/antagonist raloxifene in healthy elderly men. PARTICIPANTS: Thirty healthy men aged 60-70 years ran
Autor:
Brian R. Walker, Gerald Lobley, Alexandra M. Johnstone, Marinos Elia, Ruth Andrew, Peter Faber, R. James Stubbs, Eileen R. Gibney
Publikováno v:
European Journal of Endocrinology. 150:185-194
Objectives: Obesity is associated with increased inactivation of cortisol by hepatic A-ring 5a- and 5b-reductases, impaired hepatic regeneration of cortisol from cortisone by 11b-hydroxysteroid dehydrogenase type 1 (11HSD1), but increased subcutaneou
Publikováno v:
European Journal of Endocrinology. :45-53
Objective: In chronic inflammatory diseases, serum levels of dehydroepiandrosterone (DHEA) sulfate (DHEAS) are low. Interestingly, several non-inflammatory diseases display similarly low levels of DHEAS which points to other inhibitory factors such a
Autor:
Mark E. Cleasby, Dawn E W Livingstone, Brian R. Walker, Jonathan R. Seckl, Moffat J. Nyirenda
Publikováno v:
European Journal of Endocrinology. :129-138
OBJECTIVE: Glucocorticoids may contribute to the association between retarded growth in utero and insulin resistance in adulthood. Administration of dexamethasone (dex) to pregnant rats results in low birth weight offspring, which develop glucose int
Autor:
Tobias Rydgren, Stellan Sandler
Publikováno v:
European Journal of Endocrinology. :543-551
OBJECTIVE: Nitric oxide (NO), generated by inducible nitric oxide synthase (iNOS), has been implicated in beta-cell destruction in type 1 diabetes. In the present study, we tested a highly selective iNOS inhibitor, 1400 W, against interleukin-1beta (
Publikováno v:
European Journal of Endocrinology. :847-854
OBJECTIVE: Glucocorticoids are important for normal brain development. Elevation or removal of these hormones can permanently modify the structure and function of the fetal brain. The purpose of this study was to examine the effects of postnatal cort